These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1444 related items for PubMed ID: 28440523

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Total neoadjuvant therapy followed by watch and wait approach or organ preservation for MRI stratified low-risk rectal cancer: early result from a prospective, single arm trial].
    Wang L, Zhao YM, Sun TT, Xu YL, Li SJ, Zhang XY, Cai Y, Li YH, Li ZW, Chen PJ, Peng YF, Wang WH, Wu AW.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar 25; 23(3):258-265. PubMed ID: 32192305
    [Abstract] [Full Text] [Related]

  • 5. [Application value of colonoscopic assessment in "watch and wait" strategy for mid-lower rectal cancer after neoadjuvant chemoradiotherapy].
    Li SJ, Wang L, Zhang XY, Li YH, Li ZW, Wu Q, Sun YS, Wu AW.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jul 25; 22(7):648-655. PubMed ID: 31302963
    [Abstract] [Full Text] [Related]

  • 6. ["Watch and wait" strategy after neoadjuvant therapy for rectal cancer: status survey of perceptions, attitudes and treatment selection in Chinese surgeons].
    Sun TT, Wang L, Yao YF, Peng YF, Zhao J, Zhan TC, Leng JH, Wang HY, Chen N, Chen PJ, Li YJ, Zhang X, Liu XZ, Zhang Y, Wu AW.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun 25; 22(6):550-559. PubMed ID: 31238634
    [Abstract] [Full Text] [Related]

  • 7. [Comparison of long-term efficacy between watch and wait strategy and total mesorectal excision in locally advanced rectal cancer patients with clinical complete response after neoadjuvant therapy].
    Wang XH, Zhou CJ, Zhang S, Wang QX, Xiao WW, Ding PR, Chen G, Pan ZZ, Zeng ZF, Gao YH.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar 25; 23(3):266-273. PubMed ID: 32192306
    [Abstract] [Full Text] [Related]

  • 8. [Long-term outcome of patients with rectal cancer who achieve complete or near complete clinical responses after neoadjuvant therapy: a multicenter registry study of data from the Chinese Watch and Wait Database].
    Zhao YM, Wang WH, Zhang W, Wang L, Li S, Wang JW, Liao LE, Yu GY, Sun Z, Qu YL, Gong Y, Lu Y, Wu T, Li YF, Wang Q, Zhao GH, Xiao Y, Ding PR, Zhang Z, Wu AW.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr 25; 27(4):372-382. PubMed ID: 38644243
    [Abstract] [Full Text] [Related]

  • 9. The watch-and-wait strategy versus surgical resection for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy.
    Wang QX, Zhang R, Xiao WW, Zhang S, Wei MB, Li YH, Chang H, Xie WH, Li LR, Ding PR, Chen G, Zeng ZF, Wang WH, Wan XB, Gao YH.
    Radiat Oncol; 2021 Jan 19; 16(1):16. PubMed ID: 33468176
    [Abstract] [Full Text] [Related]

  • 10. Intentional Watch and Wait or Organ Preservation Surgery Following Neoadjuvant Chemoradiotherapy Plus Consolidation CAPEOX for MRI-defined Low-risk Rectal Cancer: Findings From a Prospective Phase 2 Trial (PKUCH-R01 Trial, NCT02860234).
    Wang L, Zhang XY, Zhao YM, Li SJ, Li ZW, Sun YS, Wang WH, Wu AW, Rectal Cancer Cooperative Group of Peking University Cancer Hospital.
    Ann Surg; 2023 Apr 01; 277(4):647-654. PubMed ID: 35766394
    [Abstract] [Full Text] [Related]

  • 11. Long-term Outcome of an Organ Preservation Program After Neoadjuvant Treatment for Rectal Cancer.
    Martens MH, Maas M, Heijnen LA, Lambregts DM, Leijtens JW, Stassen LP, Breukink SO, Hoff C, Belgers EJ, Melenhorst J, Jansen R, Buijsen J, Hoofwijk TG, Beets-Tan RG, Beets GL.
    J Natl Cancer Inst; 2016 Dec 01; 108(12):. PubMed ID: 27509881
    [Abstract] [Full Text] [Related]

  • 12. Oncologic outcomes of watch-and-wait strategy or surgery for low to intermediate rectal cancer in clinical complete remission after adjuvant chemotherapy: a systematic review and meta-analysis.
    Tan S, Gao Q, Cui Y, Ou Y, Huang S, Feng W.
    Int J Colorectal Dis; 2023 Oct 03; 38(1):246. PubMed ID: 37787779
    [Abstract] [Full Text] [Related]

  • 13. [Prognosis and complications of local excision for rectal cancer after neoadjuvant chemoradiotherapy].
    Li YH, Qiu XY, Lin GL, Zhou JL, Xiao Y, Qiu HZ.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Apr 25; 24(4):344-351. PubMed ID: 33878824
    [Abstract] [Full Text] [Related]

  • 14. Planned organ preservation for early T2-3 rectal adenocarcinoma: A French, multicentre study.
    Gérard JP, Barbet N, Gal J, Dejean C, Evesque L, Doyen J, Coquard R, Gugenheim J, Benizri E, Schiappa R, Baudin G, Benezery K, François E.
    Eur J Cancer; 2019 Feb 25; 108():1-16. PubMed ID: 30580125
    [Abstract] [Full Text] [Related]

  • 15. Changing operative strategy from abdominoperineal resection to sphincter preservation in T3 low rectal cancer after downstaging by neoadjuvant chemoradiation: a preliminary report.
    Madbouly KM, Hussein AM.
    World J Surg; 2015 May 25; 39(5):1248-56. PubMed ID: 25561197
    [Abstract] [Full Text] [Related]

  • 16. Is neoadjuvant chemoradiation with dose-escalation and consolidation chemotherapy sufficient to increase surgery-free and distant metastases-free survival in baseline cT3 rectal cancer?
    São Julião GP, Habr-Gama A, Vailati BB, Aguilar PB, Sabbaga J, Araújo SEA, Mattacheo A, Alexandre FA, Fernandez LM, Gomes DB, Gama-Rodrigues J, Perez RO.
    Eur J Surg Oncol; 2018 Jan 25; 44(1):93-99. PubMed ID: 29217398
    [Abstract] [Full Text] [Related]

  • 17. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL, Meng WJ, Shu P, Deng XB, Wu B, Jiang D, Zhuang H, Shen YL, Zhou ZG, Wang ZQ, Wang X.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr 25; 22(4):349-356. PubMed ID: 31054549
    [Abstract] [Full Text] [Related]

  • 18. [Short-term outcome of programmed cell death protein1 (PD-1) antibody combined with total neoadjuvant chemoradiotherapy in the treatment of locally advanced middle-low rectal cancer with high risk factors].
    Li YJ, Zhang L, Dong QS, Cai Y, Zhang YZ, Wang L, Yao YF, Zhang XY, Li ZW, Li YH, Sun YS, Wang WH, Wu AW.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov 25; 24(11):998-1007. PubMed ID: 34823301
    [Abstract] [Full Text] [Related]

  • 19. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis.
    Renehan AG, Malcomson L, Emsley R, Gollins S, Maw A, Myint AS, Rooney PS, Susnerwala S, Blower A, Saunders MP, Wilson MS, Scott N, O'Dwyer ST.
    Lancet Oncol; 2016 Feb 25; 17(2):174-183. PubMed ID: 26705854
    [Abstract] [Full Text] [Related]

  • 20. Wait-and-see or radical surgery for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy: a cohort study.
    Li J, Liu H, Yin J, Liu S, Hu J, Du F, Yuan J, Lv B, Fan J, Leng S, Zhang X.
    Oncotarget; 2015 Dec 08; 6(39):42354-61. PubMed ID: 26472284
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 73.